Citation Impact

Citing Papers

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Global Patterns of Groundwater Table Depth
2013 StandoutScience
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Caloric restriction leads to high marrow adiposity and low bone mass in growing mice
2010
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
Distribution and Metabolism of Calcium Leucovorin in Normal and Tumor Tissue
1988
Platinum-based chemotherapy in metastatic breast cancer: current status
2003
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
1992
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Cushing's syndrome
2015 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Osteomyelitis
1997 Standout
Head and neck cancer
2008 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Multidrug resistance (mdr) genes in human cancer
1991
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial
1996
Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition
1996
A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat
1999
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
1997
Cellular processing of platinum anticancer drugs
2005 Standout
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.
1995
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Platinum Compounds in the Treatment of Advanced Breast Cancer
2001
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
Head and Neck Cancer
1993 Standout
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
1992
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Pharmacological considerations in the modulation of multidrug resistance
1996
Cardiovascular Responses to Glutamate and Angiotensin II in Ventrolateral Medulla of Hypertension Induced by Chronic Inhibition of Nitric Oxide.
2000
Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer
2004
Modeling pO2 Distributions in the Bone Marrow Hematopoietic Compartment. I. Krogh's Model
2001
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations
2004 Standout
What We Talk About When We Talk About Fat
2014 Standout
ZD0473 treatment in lung cancer: an overview of the clinical trial results
2002
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
1993
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
A role for leptin and its cognate receptor in hematopoiesis
1996
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Platinum drugs in the treatment of non-small-cell lung cancer
2002
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1990
Head and Neck Cancer
2001 Standout
Strategies for reversing drug resistance
2003
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Tumour stem cells and drug resistance
2005 Standout
Changing role of chemotherapy in treatment of head and neck cancer
1982
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program
1994
Lung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases
1985
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
1998
Adult T-cell leukemia: clinical and hematologic features of 16 cases
1977 Standout
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus
1994
9 Hormone production by tumours: Biological and clinical aspects
1985
Leaf characteristics, wood anatomy and hydraulic properties in tree species from contrasting habitats within upper Rio Negro forests in the Amazon region
2010
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Understanding Adipocyte Differentiation
1998 Standout
Nitric Oxide Modulates Anoxia-Induced Gasping in the Developing Rat
1998
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
1999
The presence and distribution of reduced folates in Escherichia coli dihydrofolate reductase mutants.
1990 StandoutNobel
Marrow Fat and Bone—New Perspectives
2013
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.
1989
Pathophysiology of Sleep Apnea
2010 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Hypothesis: differentiation of the human lymphoid system based on cell surface markers
1975
Neither l -Arginine nor L-NAME Affects Neurological Outcome After Global Ischemia in Cats
1997
The Protective Effect of Late Preconditioning Against Myocardial Stunning in Conscious Rabbits Is Mediated by Nitric Oxide Synthase
1997
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Angiotensin in the Nucleus Tractus Solitarii Contributes to Neurogenic Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition
2000
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout

Works of Stephen Davis being referenced

The response of LiF thermoluminescence dosemeters to photon beams in the energy range from 30 kV X rays to 60Co gamma rays
2003
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
1990
Chemotherapy with cis-Platin, Doxorubicin, and Cyclophosphamide (CAP) in Patients with Metastatic Breast Cancer
1989
Elevated prolactin levels in bronchogenic carcinoma
1979
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients
1987
Levamisole as an adjuvant to chemotherapy in extensive bronchogenic carcinoma. A veterans administration lung cancer group study
1982
The Role of the Lymphocyte in Producing the Clinical Manifestations of Chronic Lymphocytic Leukeniia
1973
Vindesine and mitomycin c in chemotherapy refractory advanced breast cancer
1986
Biophysical Perspectives of Xylem Evolution: is there a Tradeoff of Hydraulic Efficiency for Vulnerability to Dysfunction?
1994
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole
1986
Pharmacokinetics of vincristine in cancer patients treated with nifedipine
1989
Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck
1979
Nitro -l- Arginine Analogues
1995
Small-cell carcinoma of the lung—survival according to histologic subtype: A veterans administration lung group study
1981
NITRO-L-ARGININE ANALOGUES: DOSE-AND TIME RELATED NITRIC OXIDE SYNTHASE INHIBITION IN BRAIN
1994
Bone marrow adipose tissue: Response to acute starvation
1979
Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy
1986
Marrow adipose tissue: Response to erythropoiesis
1978
Rankless by CCL
2026